FindingPheno

The University of Copenhagen (UCPH) was founded in 1479 and today has approximately 39,000 students and 9,000 employees – of whom about 5,000 are researchers, making it the largest research and educational institution in the Nordic countries. The diversity of research programs and scientific expertise at UCPH is a distinguishing feature of the university.

The UCPH researchers participating in FindingPheno come from two departments, The Globe Institute and the Department of Mathematical Sciences. The combined expertise of these UCPH researchers spans applied statistics, machine learning, evolutionary genomics, population genomics and industrial microbiome research.

The University of Turku (UTU) was established in 1920 but its roots reach back to the Royal Academy of Turku in the 1650s. Today, UTU has almost 20,000 students and 3,271 staff members. 

The UTU researchers participating in FindingPheno come from the Turku Data Science Group within the Department of Computing. This group is headed by Assoc. Prof. Leo Lahti and combines theory and methods of algorithmic data analysis, with a particular focus on probabilistic machine learning, complex systems, high-throughput data analysis and statistical programming. 

The Centre for Ecological Research is the largest ecology institute in Hungary, and therefore it is dedicated to being an advisor to the nation on issues related to biodiversity and ecosystems, and also responsible for supporting the development of ecology in Hungary. There are four institutes within the Centre, the Balaton Limnological Institute, the Danube Research Institute, the Institute of Evolution and the Institute of Ecology and Botany. These Institutes work on integrating disciplines as the solution to our environmental problems cannot be solved in isolation.

The Champalimaud Foundation (CF) is a private, non-profit organisation dedicated to research excellence in biomedical science. Completed in 2010, the Champalimaud Centre for the Unknown (CCU) is a state-of-the-art centre for basic and translational research, diagnosis and treatment of diseases from neurological disorders to cancer. CF provides a unique environment for cutting-edge research designed to reveal new knowledge and develop scientific solutions to medical problems.

The European Molecular Biology Laboratory (EMBL) is Europe’s flagship laboratory for the life sciences, with more than 80 independent groups covering the spectrum of molecular biology. The cornerstones of EMBL’s mission are to: perform basic research in molecular biology; train scientists, students and visitors at all levels; offer vital services to scientists in the member states; develop new instruments and methods in the life sciences and actively engage in technology transfer activities; and integrate European life science research.

QIAGEN Aarhus was founded in 2005 and has specialized in software tools for Next Generation Sequencing (NGS) analysis. The CLC Genomics Workbench and CLC Microbial Genomics Module, produced by QIAGEN Aarhus, are a world leading software suite for NGS analysis of bacterial sequences, including de novo mapping, typing and metagenomics capabilities. We have a customer base of more than 50,000 active users, a global and highly skilled sales team, and a professional ISO-certified quality software development setup.

Chr. Hansen A/S is a global bioscience company with 3000+ employees distributed all over the world. We develop natural solutions for the food, nutritional, pharmaceutical and agricultural industries covering entire production chains. We use strong R&D competencies coupled with significant technology investments and close customer relationships to develop and produce cultures, enzymes, and natural colours for a variety of foods, confectionery, beverages, dietary supplements and animal feed. The department of Animal Health aims at increasing the intestinal health and digestibility for production animals through microbiomes and knowledge.

Njorth Bio_science Ltd. was founded in 2017 as the link between Njorth Bio AS in Tromsø and the Cambridge research hub for handling the biodiscovery parts of enzyme development. All activities related to the development of new enzymes are taking place at Cambridge, where we work all the way from bioinformatics to final enzyme development. Our core philosophy is to use a wide integration of omics tools to accelerate and economise enzyme development rather than having the biotech industry relying on cumbersome and traditional functional screening approaches.